Your browser doesn't support javascript.
loading
Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML.
Bultitude, Will P; Schellekens, Jennifer; Szydlo, Richard M; Anthias, Chloe; Cooley, Sarah A; Miller, Jeffrey S; Weisdorf, Daniel J; Shaw, Bronwen E; Roberts, Chrissy H; Garcia-Sepulveda, Christian A; Lee, Julia; Pearce, Rachel M; Wilson, Marie C; Potter, Michael N; Byrne, Jenny L; Russell, Nigel H; MacKinnon, Stephen; Bloor, Adrian J; Patel, Amit; McQuaker, I Grant; Malladi, Ram; Tholouli, Eleni; Orchard, Kim; Potter, Victoria T; Madrigal, J Alejandro; Mayor, Neema P; Marsh, Steven G E.
Afiliação
  • Bultitude WP; Anthony Nolan Research Institute, Royal Free Hospital, London, UK.
  • Schellekens J; Cancer Institute, University College London, Royal Free Campus, London, UK.
  • Szydlo RM; Anthony Nolan Research Institute, Royal Free Hospital, London, UK.
  • Anthias C; Cancer Institute, University College London, Royal Free Campus, London, UK.
  • Cooley SA; Anthony Nolan Research Institute, Royal Free Hospital, London, UK.
  • Miller JS; Imperial College London, London, UK.
  • Weisdorf DJ; Anthony Nolan Research Institute, Royal Free Hospital, London, UK.
  • Shaw BE; Royal Marsden Hospital, Surrey, UK.
  • Roberts CH; Fate Therapeutics, San Diego, CA, USA.
  • Garcia-Sepulveda CA; Haematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA.
  • Lee J; Haematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA.
  • Pearce RM; CIBMTR and Froedtert and the Medical College of Wisconsin Clinical Cancer Center, Wisconsin, WI, USA.
  • Wilson MC; London School of Hygiene and Tropical Medicine, London, UK.
  • Potter MN; Laboratorio de Genómica Viral y Humana, Facultad de Medicina, Universidad Autónoma de San Luis Potosi, San Luis Potosi, SLP, Mexico.
  • Byrne JL; British Society of Blood and Marrow Transplantation and Cellular Therapy, Guy's Hospital, London, UK.
  • Russell NH; British Society of Blood and Marrow Transplantation and Cellular Therapy, Guy's Hospital, London, UK.
  • MacKinnon S; Anthony Nolan Research Institute, Royal Free Hospital, London, UK.
  • Bloor AJ; British Society of Blood and Marrow Transplantation and Cellular Therapy, Guy's Hospital, London, UK.
  • Patel A; Royal Marsden Hospital, Surrey, UK.
  • McQuaker IG; Nottingham University Hospital, Nottingham, UK.
  • Malladi R; Nottingham University Hospital, Nottingham, UK.
  • Tholouli E; University College London Hospitals NHS Foundation Trust, London, UK.
  • Orchard K; The Christie NHS Foundation Trust, Manchester, UK.
  • Potter VT; Liverpool University Hospital, Liverpool, UK.
  • Madrigal JA; West of Scotland Cancer Centre, Gartnavel General Hospital, Glasgow, UK.
  • Mayor NP; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Marsh SGE; Manchester University NHS Foundation Trust, Manchester, UK.
Bone Marrow Transplant ; 55(10): 1975-1984, 2020 10.
Article em En | MEDLINE | ID: mdl-32203258
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Receptores KIR Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Receptores KIR Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article